Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1976-9-1
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0014-5793
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
64
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
341-5
|
| pubmed:dateRevised |
2005-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:1278389-Complement C1,
pubmed-meshheading:1278389-Complement System Proteins,
pubmed-meshheading:1278389-Dose-Response Relationship, Drug,
pubmed-meshheading:1278389-Humans,
pubmed-meshheading:1278389-Solutions,
pubmed-meshheading:1278389-Structure-Activity Relationship,
pubmed-meshheading:1278389-Ultracentrifugation
|
| pubmed:year |
1976
|
| pubmed:articleTitle |
Ultracentrifugation studies on the native form of the first component of human complement (C1).
|
| pubmed:publicationType |
Journal Article
|